Concerns over misuse, side effects and counterfeits are tightening controls on the blockbuster treatments, says Iona ...
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...
Former Latham & Watkins global vice chair joins the firm as co-chair of its technology transactions practice | New partner ...